Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Alexandra Marvar
Right Under Your Nose: Diagnosing Alzheimer’s in a Sneeze?
Can Memory Loss Be Reversed? Experimental Drug Heads to Clinical Trials
9/11 First Responders Show Signs of Dementia
A Safer Dementia-Related Psychosis Treatment Grows Closer to FDA Approval
Study: 1/3 of People with Dementia Have Access to Firearms at Home
5 Reasons The Pandemic Caused a Surge in Alzheimer’s Deaths
Meet BACE2, a Gene That Can Naturally Suppress Alzheimer’s
This Discovery May Speed Up Alzheimer’s Drug Testing
What If You Could Get the Brain-Boosting Benefits of Six Weeks of Exercise in a Pill?
A Common Asthma Drug Shows Promise as a Treatment for Alzheimer’s
Childhood Education & Alzheimer’s: Early Learning May Help Prevent Cognitive Decline in Old Age
The Prevagen Settlement & the Wild West of Brain Health Supplements
Alzheimer’s Researchers Bring in the Baboons
‘It’s Time to Act’: A New 5-Year Plan to Relieve Alzheimer’s Burden on Women
Cancer Drug Nilotinib Shows Promise for Treatment of Alzheimer’s
Previous
5
6
7
Next
Page load link
Go to Top